Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methodology Study to Investigate the Utility of Retroviral Insertion Site Analysis in Samples From Subjects Treated With Strimvelis Gene Therapy.

NCT04959890 is registered in ClinicalTrials.gov with Fondazione Telethon as lead sponsor.

NCT NCT04959890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04959890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methodology Study to Investigate the Utility of Retroviral Insertion Site Analysis in Samples From Subjects Treated With Strimvelis Gene Therapy.
Lead sponsor
Fondazione Telethon
Phase
Observational
Overall status
Unknown status
Start date
April 23, 2021
Completion date
March 31, 2024
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe combined immunodeficiency due to ada deficiency